NCT07010770 SMART Therapist Training: A Hybrid Factorial-SMART Design
| NCT ID | NCT07010770 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Stress Disorders, Post-Traumatic |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2025-08-15 |
| Primary Completion | 2030-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2025-08-15 with a primary completion date of 2030-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cognitive Processing Therapy (CPT) is highly effective in randomized controlled trials, but its effectiveness drops substantially in standard clinical practice, largely due to therapist "drift" from fidelity to the protocol. What remains unknown is which components of CPT training yield high therapist fidelity. Thus, there is a critical need to use empirical approaches to identify the most effective components of CPT training and to develop an adaptive training model for CPT by testing sequences of empirically-supported training strategies. The long-term goal of this research is to develop a sustainable model of therapy training that is personalized to the needs of the therapist trainee. The overall objective of this application is to empirically optimize an adaptive model for CPT training. The rationale is that developing an adaptive training model will improve efficiency and personalization, yield higher fidelity, and ultimately improve Veteran outcomes. We expect that completion of this project will produce an adaptive CPT training program that yields high therapist fidelity. Improving CPT fidelity in VHA will have a positive impact on the health and wellbeing of Veterans with PTSD.
Eligibility Criteria
Inclusion Criteria: We have designed the sample to be representative of therapists who are eligible for CPT rollout training. * Participants must be licensed mental health clinicians or a mental health trainee in VA service (e.g., practicum students, psychology interns, postdoctoral fellows) whose formal job responsibilities include the provision of psychotherapy services to Veterans on a regular basis * Participants must be able to participate for 9 months. * Participants must work in a setting where CPT may be implemented (12 weekly 60-minute individual sessions or 90-minute group sessions). * Participants must have local/supervisor support to implement CPT and fully participate in all training and consultation activities. * Participating trainees (e.g. psychology interns) on a 6-month training rotation must have permission from their supervisors to continue the study into their next rotation. Exclusion Criteria: * Participant is not a licensed mental health clinician * Participant is already certified in CPT
Contact & Investigator
Rebecca Kaufman Sripada, PhD MS
PRINCIPAL INVESTIGATOR
VA Ann Arbor Healthcare System, Ann Arbor, MI
Frequently Asked Questions
Who can join the NCT07010770 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stress Disorders, Post-Traumatic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07010770 currently recruiting?
Yes, NCT07010770 is actively recruiting participants. Contact the research team at rebecca.sripada@va.gov for enrollment information.
Where is the NCT07010770 trial being conducted?
This trial is being conducted at Palo Alto, United States, Ann Arbor, United States, Minneapolis, United States, Cincinnati, United States.
Who is sponsoring the NCT07010770 clinical trial?
NCT07010770 is sponsored by VA Office of Research and Development. The principal investigator is Rebecca Kaufman Sripada, PhD MS at VA Ann Arbor Healthcare System, Ann Arbor, MI. The trial plans to enroll 240 participants.